116 related articles for article (PubMed ID: 2813453)
1. Protection of 3'-azido-3'-deoxythymidine induced toxicity to murine hematopoietic progenitors (CFU-GM, BFU-E and CFU-MEG) with interleukin-1.
Gallicchio VS; Doukas MA; Hulette BC; Hughes NK; Gass C
Proc Soc Exp Biol Med; 1989 Nov; 192(2):201-4. PubMed ID: 2813453
[TBL] [Abstract][Full Text] [Related]
2. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
3. [Demonstration of a protector effect of interleukin-1 against hematologic toxicity of azidothymidine (AZT)].
Arock M; Dedenon A; Damais C; Averlant G; Guillosson JJ
C R Seances Soc Biol Fil; 1992; 186(3):206-14. PubMed ID: 1493577
[TBL] [Abstract][Full Text] [Related]
4. Prevention of the hematopoietic toxicity associated with zidovudine in vivo with IL-1 alone or in combination with GM-CSF administered to normal mice.
Gallicchio VS; Hughes NK; Tse KF; Gaines H
Growth Factors; 1993; 9(3):177-83. PubMed ID: 8274295
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor (B-FGF) induces early- (CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro.
Gallicchio VS; Hughes NK; Hulette BC; DellaPuca R; Noblitt L
Int J Cell Cloning; 1991 May; 9(3):220-32. PubMed ID: 2061622
[TBL] [Abstract][Full Text] [Related]
7. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro.
Gallicchio VS; Hughes NK; Tse KF
Int J Immunopharmacol; 1993 Feb; 15(2):263-8. PubMed ID: 8468123
[TBL] [Abstract][Full Text] [Related]
9. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors.
Gallicchio VS; Hughes NK
Int J Cell Cloning; 1992 Mar; 10(2):99-104. PubMed ID: 1545155
[TBL] [Abstract][Full Text] [Related]
10. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
[TBL] [Abstract][Full Text] [Related]
11. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
12. Effective modulation of the haematopoietic toxicity associated with zidovudine exposure to murine and human haematopoietic progenitor stem cells in vitro with lithium chloride.
Gallicchio VS; Hughes NK
J Intern Med; 1992 Mar; 231(3):219-26. PubMed ID: 1313488
[TBL] [Abstract][Full Text] [Related]
13. Influence of human granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein (PIXY321) on the hematopoietic toxicity associated with anti-viral drugs (zidovudine and didanosine) in vitro using normal human marrow cells.
Gallicchio VS; Hughes NK
Life Sci; 1995; 57(18):PL265-73. PubMed ID: 7475901
[TBL] [Abstract][Full Text] [Related]
14. Microenvironmental toxicity of azidothymidine: partial sparing with hemin.
Abraham NG; Bucher D; Niranjan U; Brown AC; Lutton JD; Distenfeld A; Ahmed T; Levere RD
Blood; 1989 Jul; 74(1):139-44. PubMed ID: 2752105
[TBL] [Abstract][Full Text] [Related]
15. Specificity of heme for hemopoietic recovery from AZT toxicity.
Loewy G; Cook P; Ahmed T; Lutton JD; Nishimura M; Distenfeld A; Levere RD; Abraham NG
Hematol Pathol; 1992; 6(2):79-85. PubMed ID: 1607343
[TBL] [Abstract][Full Text] [Related]
16. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors.
Grillon C; Bonnet D; Mary JY; Lenfant M; Najman A; Guigon M
Stem Cells; 1993 Sep; 11(5):455-64. PubMed ID: 8241956
[TBL] [Abstract][Full Text] [Related]
17. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
Castello G; Mela G; Cerruti A; Mencoboni M; Lerza R
Exp Hematol; 1995 Dec; 23(13):1367-71. PubMed ID: 7498365
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG
Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696
[TBL] [Abstract][Full Text] [Related]
19. Influence of interleukin-3 (IL-3) on the hematopoietic toxicity associated with combination anti-viral drugs (zidovudine and DDI) in vitro using retrovirus-infected bone marrow cells.
Gallicchio VS; Hughes NK
Int J Immunopharmacol; 1994 Apr; 16(4):359-66. PubMed ID: 8045675
[TBL] [Abstract][Full Text] [Related]
20. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.
Hangoc G; Williams DE; Falkenburg JH; Broxmeyer HE
J Immunol; 1989 Jun; 142(12):4329-34. PubMed ID: 2656864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
